InMed Pharmaceuticals Inc. sell Vassago1
Start price
12.09.22
/
50%
€16.34
Target price
12.09.23
-
Performance (%)
-93.70%
End price
02.04.23
€1.03
Summary
This prediction ended on 02.04.23 with a price of €1.03. Vassago1 correctly predicted massive losses of -93.70% for InMed Pharmaceuticals Inc.. Vassago1 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| InMed Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% | 65.619% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% | 111.545% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% | 56.683% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% | 68.722% |
According to Vassago1 what are the pros and cons of InMed Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Vassago1 for this prediction
In the thread Trading InMed Pharmaceuticals Inc.
In the thread Inmed Pharmaceuticals Inc. diskutieren
Sell Inmed Pharmaceuticals Inc.